Risk Factors for Developing Adenovirus-Associated Post-Infectious Bronchiolitis Obliterans
- PMID: 39570082
- DOI: 10.1002/ppul.27411
Risk Factors for Developing Adenovirus-Associated Post-Infectious Bronchiolitis Obliterans
Abstract
Background: Risk factors for progression of adenovirus (AdV)-associated bronchiolitis (AdV-B) to post-infectious bronchiolitis obliterans (PIBO) are poorly defined. We aimed to investigate this in a multicenter cohort.
Methods: A multicenter hospital-based analysis included children admitted with AdV-B in Jerusalem during 2016-2022. A case-control analysis included AdV-PIBO patients in Jerusalem during 2005-2023. Cases were compared to randomly assigned controls admitted with AdV-B without progression to AdV-PIBO. Multivariate analysis with logistic regression was used.
Results: The annual incidence of AdV-B admissions and AdV-PIBO increased during 2016-2022, during which 1522 children were admitted with AdV-B and 8 developed AdV-PIBO (0.5%). Of 30 AdV-PIBO cases identified during 2005-2023, available data were compared for 25 of them (72% boys; mean age ± standard deviation 1.2 ± 0.8 years) and 139 controls (66% boys; mean age 1.0 ± 0.6 years, p = 0.5 for age). Jewish ethnicity was more common in the AdV-PIBO versus control group (92% vs. 66%, p = 0.009), as were oxygen supplementation (84% vs. 45%, p < 0.001), noninvasive ventilation (20% vs. 4%, p = 0.004), consolidations on chest X-ray (44% vs. 19%, p = 0.011), and lymphopenia (92% vs. 46%, p < 0.001). Combining Jewish ethnicity, lymphopenia, consolidations, and prolonged admission as independent risk factors yielded positive and negative predictive values of 68.8% and 90.5%, respectively.
Conclusion: These findings emphasize the urgent need for targeted preventive and management strategies. The identification of Jewish ethnicity as a risk factor may imply a genetic contribution to Adv-PIBO risk.
Keywords: PIBO; adenovirus; adenovirus‐PIBO; post‐infectious bronchiolitis obliterans; risk factors.
© 2024 Wiley Periodicals LLC.
References
-
- J. Lynch and A. Kajon, “Adenovirus: Epidemiology, Global Spread of Novel Serotypes, and Advances in Treatment and Prevention,” Seminars in Respiratory and Critical Care Medicine 37, no. 4 (2016): 586–602.
-
- A. J. Colom and A. M. Teper, “Clinical Prediction Rule to Diagnose Post‐Infectious Bronchiolitis Obliterans in Children,” Pediatric Pulmonology 44, no. 11 (2009): 1065–1069.
-
- A. Teper, A. J. Colom, R. Schubert, and P. S. Jerkic, “Update in Postinfectious Bronchiolitis Obliterans,” Pediatric Pulmonology 59, no. 9 (2024): 2338–2348.
-
- X. Yu, Y. Ma, Y. Gao, and H. You, “Epidemiology of Adenovirus Pneumonia and Risk Factors for Bronchiolitis Obliterans in Children During an Outbreak in Jilin, China,” Frontiers in Pediatrics 9 (2021): 722885.
-
- S. P. Jerkic, F. Brinkmann, A. Calder, et al., “Postinfectious Bronchiolitis Obliterans in Children: Diagnostic Workup and Therapeutic Options: A Workshop Report,” Canadian Respiratory Journal 2020 (2020): 5852827.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
